Pirmitegravir (STP0404) is a potent and selective inhibitor of allosteric integrase (ALLINI) targeting the LEDGF/p75 binding site. Pirmitegravir inhibits PBMC. Pirmitegravir inhibits PBMC.Pirmitegravir has significant antiviral activity and may be useful in the study of HIV virus infection.
Molecular Weight:
495.01
Purity:
98.98%
CAS Number:
[2245231-10-9]
Formula:
C27H31ClN4O3
Target:
HIV Protease
T39755
* VAT and and shipping costs not included. Errors and price changes excepted